Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Theurich

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Circulation Research|April 15, 2026
Deletion of PKM2 in Macrophages Promotes Stabilization but Not Regression of Atherosclerotic PlaquesFlávio Dionísio, Yeqian Zhu, Filip Prica, et al.
Journal of Hematology & Oncology|July 31, 2023
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myelomaKai Rejeski, Doris K Hansen, Radhika Bansal, et al.
Cancer Immunology Research|April 11, 2023
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell TherapyKai Rejeski, David M Cordas Dos Santos, Nathan H Parker, et al.
Nature Immunology|April 1, 2014
Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulinJan Mauer, Bhagirath Chaurasia, Julia Goldau, et al.
Blood Advances|February 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustionLisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Frontiers in Immunology|November 10, 2025
Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCCLina Ouologuem, Anna Kübler, Sarah Ouologuem, et al.
Leukemia|August 22, 2024
Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapseMaryam Kazerani, Anetta Marcinek, Nora Philipp, et al.
Blood Advances|December 1, 2025
FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell ExhaustionLisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Oncoimmunology|February 7, 2019
Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinomaAxel Lechner, Hans A Schlößer, Martin Thelen, et al.
Nature Immunology|November 23, 2021
Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responsesGesine Behrens, Stephanie L Edelmann, Timsse Raj, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Circulation Research|April 15, 2026
Deletion of PKM2 in Macrophages Promotes Stabilization but Not Regression of Atherosclerotic PlaquesFlávio Dionísio, Yeqian Zhu, Filip Prica, et al.
Journal of Hematology & Oncology|July 31, 2023
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myelomaKai Rejeski, Doris K Hansen, Radhika Bansal, et al.
Cancer Immunology Research|April 11, 2023
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell TherapyKai Rejeski, David M Cordas Dos Santos, Nathan H Parker, et al.
Nature Immunology|April 1, 2014
Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulinJan Mauer, Bhagirath Chaurasia, Julia Goldau, et al.
Blood Advances|February 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustionLisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Frontiers in Immunology|November 10, 2025
Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCCLina Ouologuem, Anna Kübler, Sarah Ouologuem, et al.
Leukemia|August 22, 2024
Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapseMaryam Kazerani, Anetta Marcinek, Nora Philipp, et al.
Blood Advances|December 1, 2025
FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell ExhaustionLisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Oncoimmunology|February 7, 2019
Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinomaAxel Lechner, Hans A Schlößer, Martin Thelen, et al.
Nature Immunology|November 23, 2021
Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responsesGesine Behrens, Stephanie L Edelmann, Timsse Raj, et al.
Pageof 15